ICE T-TIMI 49 was a randomized, open-label, multicenter, placebo-controlled pilot study to evaluate the feasibility and safety of a 4mg IC TNK administered before and following PPCI with protocol-mandated aspirin, clopidogrel, unfractionated heparin, and intravenous glycoprotein IIb/IIIa inhibition. MAIN RESULTS: Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial … Continue reading ICE T-TIMI 49